- Afkhami-Ardekani, M., Kamali-Ardekani, A. and Shojaoddiny-Ardekani, A. (2006). Effects of garlic on serum lipids and blood glucose of type 2 diabetic patients. Int. J. Diab. Dev. Ctries. 26: 86-88.
- Al-Sultan, S. and Gameel, A. (2004). Histopathological changes in the livers of broiler chicken supplemented with turmeric (Curcuma longa). Int. J. Poultry Sci. 3: 333-336.
- Anjum, K., Sayyed, U., Ullah, A., Mughal, M., Yaqub, A., Rashid, M. and Yousaf, M. (2014). Antihypercholesterolemic and anti- atherogenic activity of Terminalia chebula fruit in normal and cholesterol fed rabbits. J. Anim. Plant Sci. 24: 1618-1622.
- Ashraf, M.Z., Hussain, M. and Fahim, M. (2005). Antiatherosclerotic effects of dietary supplementations of garlic and turmeric: Restoration of endothelial function in rats. Life Sci. 77: 837-857.
- Banerjee Sanjay, K. and Maulik Subir, K. (2002). Effect of garlic on cardiovascular disorders: a review. Nut. J. 1: 1-4.
- Braun, L. and Cohen, M. (2010). Herbs and Natural Supplements: An Evidence-based Guide Third Edition. J. Aust. Coll. Nut. Env. Med. 29: 13-17.
- Brunton, L., Lazo, J. and Parker, K.G. (2005). Gilman’s The Pharmacological Basis of Therapeutics. 11th. New York: Mc Graw-Hill.
- Bundy, R., Walker, A.F., Middleton, R.W. and Booth, J. (2004). Turmeric extract may improve irritable bowel syndrome symptomology in otherwise healthy adults: a pilot study. J. Alte. Comp. Med. 10: 1015-1018.
- Colpo, A. (2005). LDL Cholesterol:” Bad” Cholesterol or Bad Science? J. Am. Phys. Surg. 10: 83.
- Donato, A.J., Eskurza, I., Silver, A.E., Levy, A.S., Pierce, G.L., Gates, P.E. and Seals, D.R. (2007). Direct evidence of endothelial oxidative stress with aging in humans. Circulation Res. 100: 1659-1666.
- Itokawa, H., Shi, Q., Akiyama, T., Morris-Natschke, S.L. and Lee, K.-H. (2008). Recent advances in the investigation of curcuminoids. Chinese Med. 3: 11-16.
- Kumar, A. and Singh, V. (2010). Atherogenic dyslipidemia and diabetes mellitus: what’s new in the management arena? Vas. Heal. Risk Manag. 6: 665-669.
- Levine, G.N., Keaney Jr, J.F. and Vita, J.A. (1995). Cholesterol reduction in cardiovascular disease—clinical benefits and possible mechanisms. New Eng. J. Med. 332: 512-521.
- Liu, L. and Yeh, Y.-Y. (2002). S-alk (en) yl cysteines of garlic inhibit cholesterol synthesis by deactivating HMG-CoA reductase in cultured rat hepatocytes. J. Nut. 132: 1129-1134.
- Pari, L. and Umamaheswari, J. (2000). Antihyperglycaemic activity of Musa sapientum flowers: effect on lipid peroxidation in alloxan diabetic rats. Phytother. Res. 14:136-138.
- Podrez, E.A. (2013). Bad versus good cholesterol in the bone marrow. Nature Med. 19: 541-543.
- Pollex, R.L., Joy, T.R. and Hegele, R.A. (2008). Emerging antidyslipidemic drugs. Exp. Opi. Emerg. Drug. 13: 363-381.
- Santoshkumar, J. and Manjunath, S. (2013). A study of anti-hyperlipidemia, hypolipedimic and anti-atherogenic activity of fruit of Emblica officinalis (amla) in high fat fed albino rats. Int. J. Med. Res.Heal. Sci. 2: 70-77.
- Stevinson, C., Pittler, M.H. and Ernst, E. (2000). Garlic for treating hypercholesterolemiaA Meta-Analysis of randomized clinical trials. Annals Inter. Med. 133: 420-429.
- Sukandar, E.Y., Sigit, J.I. and Deviana, R. (2013). Antihyperlipidemic and antidiabetic effect of combination of garlic and turmeric extract in rats. J. Med. Plant. 1: 5-10.
- Sukandar, E.Y., Sudjana, P., Sigit, J.I., Leliqia, N.P.E. and Lestari, F. (2013). Safety of garlic (Allium Sativum) and turmeric (Curcuma domestica) extract in comparison with simvastatin on improving lipid profile in dyslipidemia patients. J. Med. Sci. 13: 10-13.
- Thompson Coon, J. and Ernst, E. (2002). Herbal medicinal products for non-ulcer dyspepsia. Ali. Pharm. Ther. 16: 1689-1699.
- Zahid, S., Anjum, K. M., Mughal, M. S., Yaqub, A. and Yameen, M. (2018). Evaluation of antioxidant and anti-hyperlipidemic activity of Emblica officinalis (Indian gooseberry) fruit in high fat fed rabbits. J. Anim. Plant Sci. 28: 1007-1013.
Submitted Date : 12-04-2018
Accepted Date : 5-04-2019
First Online: